Innovative NeuroTechnologies

Innovative NeuroTechnologies, Inc. (INT) is a development-stage biotechnology company operating in virtual mode that is currently pursuing a pipeline of novel biologically-based and disease-modifying therapeutic solutions to prevent, delay, or mitigate the underlying dementia or cognitive impairment observed in a spectrum of neurodegenerative disor... ders referred to as tauopathies, which includes: Alzheimers disease (AD), Frontotemporal dementia (FTD or Picks disease), Chronic traumatic encephalopathy (CTE) or dementia pugilistica, Progressive supranuclear palsy (PSP), Corticobasal degeneration (CBD), Parkinson's disease dementia (PDD), and Familial form of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). The pathology of these seemingly disparate conditions is similar in that they involve dysregulation of the Tau protein and development of neurofibrillary tangles (NFTs), synaptic dysfunction, and/or neuronal loss, which underlie the observed dementia or cognitive deficits. Unfortunately, there are no effective therapies presently available for this spectrum of disorders, and neurodegenerative tauopathies remain a very significant socioeconomic burden and tremendous unmet medical need worldwide.Read More